Ligand Pharmaceuticals

Ligand Pharmaceuticals, founded in La Jolla, California, is a biopharmaceutical company focused on developing drugs that regulate hormone-activated intracellular receptors. These receptors are crucial in managing genetic processes involved in diseases such as gynecological disorders, certain cancers, cardiovascular issues, inflammatory conditions, and skin diseases. Ligand provides technology and financing solutions to advance medical innovations, with a diversified portfolio spanning cancer, kidney disease, diabetes, nonalcoholic steatohepatitis, and rare conditions.

Notable figures affiliated with Ligand Pharmaceuticals include its leadership team and key investors from the healthcare sector. The company has achieved significant milestones, including FDA approval for ZELSUVMI™. Ligand's impact is evidenced by its extensive portfolio of commercial programs marketed globally, underscoring its role as a crucial partner in healthcare investing and drug development.